Theme hub · 94 companies
Generic drugs stocks
Heavily traded in Generic drugs
Turnover over $10M/day58 of about 90 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Sep 15, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| TEVATeva Pharmaceutical Industries Limited | $179.24M | +104.98% | Nov 4, 2026 |
| 068270.KSCelltrion, Inc. | $91.78B | +7.14% | Oct 29, 2026 |
| VTRSViatris Inc. | $147.59M | +78.36% | Nov 5, 2026 |
| RDYDr. Reddy's Laboratories Limited | $30.23M | −18.59% | Oct 22, 2026 |
| 0126Z0.KSSamsung Epis Holdings Co., Ltd. | $16.07B | 0.00% | Oct 23, 2026 |
| AMRXAmneal Pharmaceuticals, Inc. | $30.21M | +75.89% | Oct 29, 2026 |
| HIK.LHikma Pharmaceuticals PLC | $1.03B | −5.23% | — |
| PRGOPerrigo Company plc | $36.77M | −35.83% | Nov 4, 2026 |
TEVA+104.98%$179.24MView analysis068270.KS+7.14%$91.78BView analysisVTRS+78.36%$147.59MView analysisRDY−18.59%$30.23MView analysis0126Z0.KS0.00%$16.07BView analysisAMRX+75.89%$30.21MView analysisHIK.L−5.23%$1.03BView analysisPRGO−35.83%$36.77MView analysisTurnover over $10M/day
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
94 companies, largest market value first.
Data as of Sep 15, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Limited | $45.12B | Large cap | +104.98% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $44.67B | Large cap | +86.47% |
| 068270.KS | Celltrion, Inc. | $30.47B | Large cap | +7.14% |
| VTRS | Viatris Inc. | $19.14B | Large cap | +78.36% |
| RDY | Dr. Reddy's Laboratories Limited | $9.92B | Mid cap | −18.59% |
| KRK.WA | Krka, d. d. | $9.04B | Mid cap | +20.94% |
| 0126Z0.KS | Samsung Epis Holdings Co., Ltd. | $6.31B | Mid cap | 0.00% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.00B | Mid cap | +75.89% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.31B | Mid cap | −5.23% |
| DMP.DE | Dermapharm Holding SE | $2.17B | Mid cap | +14.72% |
| PRGO | Perrigo Company plc | $1.89B | Small cap | −35.83% |
| ALVO-SDB.ST | Alvotech | $1.81B | Small cap | −33.24% |
| ALVO | Alvotech | $1.80B | Small cap | −37.81% |
| SPH.WA | Sopharma AD | $1.48B | Small cap | −17.07% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | $1.39B | Small cap | −48.02% |
| 4887.T | Sawai Group Holdings Co., Ltd. | $1.21B | Small cap | −17.59% |
| 4553.T | Towa Pharmaceutical Co., Ltd. | $1.13B | Small cap | +24.46% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.02B | Small cap | −12.32% |
| 001067.KS | JW Pharmaceutical Corporation | $818.59M | Small cap | −14.54% |
| 185750.KS | Chong Kun Dang Pharmaceutical Corp. | $648.48M | Small cap | −19.58% |
| DMII | Drugs Made In America Acquisition II Corp. | $648.47M | Small cap | +3.04% |
| 003850.KS | Boryung Corporation | $584.60M | Small cap | +2.97% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | $575.08M | Small cap | −35.27% |
| 4559.T | Zeria Pharmaceutical Co., Ltd. | $568.96M | Small cap | −2.11% |
| 003090.KS | Daewoong Co., Ltd. | $520.03M | Small cap | −34.53% |
| BOI.PA | Boiron SA | $513.19M | Small cap | +4.00% |
| 317450.KS | Myung In Pharmaceutical LTD. | $480.12M | Small cap | −58.27% |
| BLAU3.SA | Blau Farmacêutica S.A. | $469.06M | Small cap | +2.86% |
| 001060.KS | JW Pharmaceutical Corporation | $463.42M | Small cap | +25.49% |
| 000640.KS | Dong-A Socio Holdings Co., Ltd. | $446.58M | Small cap | −12.17% |
| 001065.KS | JW Pharmaceutical Corporation | $435.33M | Small cap | −17.80% |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | $416.38M | Small cap | −25.77% |
| FYB.DE | Formycon AG | $408.10M | Small cap | −5.07% |
| AGY.L | Allergy Therapeutics plc | $406.94M | Small cap | −42.77% |
| 019170.KS | Shinpoong Pharmaceutical Co.,Ltd | $386.35M | Small cap | −23.65% |
| 249420.KS | Ildong Pharmaceutical Co., Ltd. | $352.05M | Small cap | −41.00% |
| EBS | Emergent BioSolutions Inc. | $327.12M | Small cap | −20.25% |
| 4554.T | Fuji Pharma Co., Ltd. | $295.47M | Small cap | +16.45% |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | $292.08M | Small cap | +12.97% |
| CPH.TO | Cipher Pharmaceuticals Inc. | $270.05M | Small cap | −7.80% |
| 950210.KS | Prestige BioPharma Limited | $269.57M | Small cap | −57.52% |
| DMAA | Drugs Made In America Acquisition Corp. | $262.92M | Small cap | +5.56% |
| 170900.KS | Dong-A ST Co., Ltd. | $260.68M | Small cap | −18.10% |
| AFP.AX | AFT Pharmaceuticals Limited | $256.57M | Small cap | +49.13% |
| 009290.KS | Kwang Dong Pharmaceutical Co., Ltd. | $235.61M | Small cap | +5.96% |
| 4577.T | Daito Pharmaceutical Co.,Ltd. | $234.95M | Small cap | +9.72% |
| 004310.KS | Hyundai Pharmaceutical Co., Ltd. | $226.39M | Small cap | +153.45% |
| 096760.KS | JW Holdings Corporation | $218.33M | Small cap | +33.27% |
| 9273.T | Koa Shoji Holdings Co.,Ltd. | $205.15M | Small cap | −5.04% |
| 007575.KS | Ilyang Pharmaceutical Co.,Ltd | $186.86M | Small cap | −41.02% |
| 005500.KS | Samjin Pharmaceuticals Co., Ltd. | $172.39M | Small cap | −0.73% |
| 003520.KS | Yungjin Pharm. Co., Ltd. | $142.72M | Small cap | −47.72% |
| 016580.KS | Whan In Pharm Co.,Ltd. | $139.74M | Small cap | −6.18% |
| 001630.KS | Chong Kun Dang Holdings Corp. | $137.91M | Small cap | −19.59% |
| 102460.KS | REYON Pharmaceutical Co., Ltd. | $135.54M | Small cap | −14.45% |
| 003220.KS | Daewon Pharmaceutical Co., Ltd. | $127.38M | Small cap | −37.02% |
| 234080.KS | JW Lifescience Corporation | $125.76M | Small cap | −3.89% |
| 4538.T | Fuso Pharmaceutical Industries,Ltd. | $123.30M | Small cap | +7.05% |
| 003120.KS | Ilsung Is Co., Ltd. | $116.97M | Small cap | −6.20% |
| 293480.KS | Hana Pharm Co., Ltd. | $109.88M | Small cap | −27.97% |
| 271980.KS | Jeil Pharmaceutical Co.,Ltd | $109.54M | Small cap | −27.33% |
| 007570.KS | Ilyang Pharmaceutical Co.,Ltd | $107.87M | Small cap | −38.12% |
| 000020.KS | Dongwha Pharm.Co.,Ltd | $106.86M | Small cap | −18.53% |
| BGM | BGM Group Ltd. | $102.00M | Small cap | −96.76% |
| 214390.KS | Kyongbo Pharmaceutical Co., Ltd | $96.44M | Micro cap | −1.54% |
| 001360.KS | SAMSUNG PHARM. Co., LTD. | $96.43M | Micro cap | −19.01% |
| 002390.KS | HANDOK Inc. | $89.76M | Micro cap | −18.14% |
| 002620.KS | Jeil Pharma Holdings Inc | $87.91M | Micro cap | −12.34% |
| 4574.T | Taiko Pharmaceutical Co.,Ltd. | $82.87M | Micro cap | −15.78% |
| 4524.T | Morishita Jintan Co., Ltd. | $59.87M | Micro cap | +3.93% |
| 063160.KS | CKD Bio Corp. | $52.95M | Micro cap | −44.39% |
| 000230.KS | Ildong Holdings Co., Ltd. | $52.58M | Micro cap | −36.39% |
| 002720.KS | Kukje Pharma Co., Ltd. | $51.76M | Micro cap | −28.07% |
| 004720.KS | PharmGen Science, Inc. | $48.34M | Micro cap | −34.29% |
| 000220.KS | Yuyu Pharma, Inc. | $44.98M | Micro cap | −7.82% |
| 4539.T | Nippon Chemiphar Co., Ltd. | $36.54M | Micro cap | −0.48% |
| CPHI | China Pharma Holdings, Inc. | $33.49M | Micro cap | −57.84% |
| 017180.KS | MYUNGMOON Pharm co.,Ltd | $32.59M | Micro cap | −24.87% |
| RMTI | Rockwell Medical, Inc. | $31.36M | Micro cap | +368.67% |
| 000225.KS | Yuyu Pharma, Inc. | $28.80M | Micro cap | −17.76% |
| COSM | Cosmos Health Inc. | $27.10M | Micro cap | −70.11% |
| 000227.KS | Yuyu Pharma, Inc. | $26.72M | Micro cap | −26.70% |
| UPC | Universe Pharmaceuticals INC | $24.17M | Micro cap | +23.33% |
| 003060.KS | Aprogen Biologics Inc. | $16.11M | Micro cap | −82.44% |
| AEON | AEON Biopharma, Inc. | $14.28M | Micro cap | −63.80% |
| ACUC.ST | AcuCort AB (publ) | $13.21M | Micro cap | +9.81% |
| FRE.AX | Firebrick Pharma Limited | $6.15M | Micro cap | −55.22% |
| ACR.AX | Acrux Limited | $4.76M | Micro cap | −26.67% |
| EVE.AX | EVE Health Group Limited | $4.27M | Micro cap | −39.29% |
| SBFM | Sunshine Biopharma, Inc. | $4.15M | Micro cap | −27.70% |
| SXTC | China SXT Pharmaceuticals, Inc. | $3.51M | Micro cap | −99.05% |
| BIOM3F.SA | BIOMM ON N2 | — | — | −3.28% |
| BLAU3F.SA | BLAU ON NM | — | — | −5.76% |
| SDZ.SW | Sandoz Group AG | — | — | +43.91% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 94 companies grouped under the Generic drugs theme. The median market value in the group is $234.95M. Across the group, the median move over the past trading day is +0.24%. 23% of the 90 with a 200-day average trade above it. Price change over the past year runs from −47.9% to +25.2% across the middle 80 percent of the group, with a median of −15.2%.
Other lists in this group
Generic drugsAdvanced packagingAerospaceAgriculture and agribusinessAI applicationsAI chipsAI datacenter infrastructureAirlinesAlcoholic beveragesAlternative asset managersAluminumApparel and footwearAR VR mixed realityAsset managementAuto partsAutomotive OEMsAutonomous driving softwareBeauty and personal careBiofuelsBitcoin miningBlockchain platformsBrokerage and exchangesBuilding productsCannabisAll stocks
The other 156 themes
Carbon captureCarbon creditsCasual diningCell therapyCell tower REITCement and aggregatesCoal miningCobaltCommercial office REITCommodity chemicalsComputer visionConstruction and engineeringConsumer financeContainers and packagingContract research CDMOCopper miningCredit rating and dataCruise linesCryptocurrency and digital assetsCybersecurityData platformsDatacenter coolingDatacenter powerDatacenter REITDefense electronicsDefense prime contractorsDental careDeveloper toolsDiabetes careDiagnosticsDiamonds and gemstonesDiscount retailDrones and UAVEcommerce marketplacesEcommerce platformsEdge computingEdtechElectrical equipmentEnergy storageEsportsEV batteriesEV chargingEV makersFast food and quick serviceFintech softwareGambling and casinosGaming softwareGene therapyGenerative AIGeothermalGLP 1 and obesityGold miningGPU cloud computeGraphiteGrocery and supermarketsHealth insuranceHealthcare REITHealthtech softwareHome improvementHomebuildersHospitals and providersHotel REITHotels and hospitalityHousehold productsHR techHVAC and controlsHydroelectricHydrogen economyIndustrial automationIndustrial gasesIndustrial machineryIndustrial REITInsurance brokersInvestment bankingIoT platformsIron oreLife insuranceLife science toolsLithium miningLogistics and 3PLLong term careLumber and forestryLuxury goodsMarine shippingMartech adtechMedical devicesMemory storage semisMissiles and munitionsMoney center banksMortgage financeMortgage REITmRNA platformsNatural gas utilitiesNeobanks and digital banksNeuroscienceNickelNon alcoholic beveragesNuclear powerOil and gas explorationOil and gas midstreamOil and gas refiningOil and gas servicesOncologyOnline travelPackaged foodsPayment processingPet carePharmaceuticals large capPotash fertilizerProperty casualty insurancePsychedelic therapeuticsQuantum computingRail transportRare diseaseRare earthsReal estate servicesRegional banksRegulated electric utilitiesReinsuranceRenewable energy developersResidential REITRetail REITRide hailing and deliveryRobotics hardwareSaaSSelf storage REITSemiconductor designSemiconductor equipmentSemiconductor manufacturingShipbuildingSilver miningSocial mediaSolarSpace launch and satellitesSpecialty chemicalsSpecialty financeSpecialty REITSpecialty retailSpeech and audio AISteelStreaming mediaSupply chain softwareSurgical roboticsTelecom equipmentTelecom infrastructureTelemedicineTobacco and nicotineTravel and leisureTrucking and LTLUranium miningVeterinary and animal healthVision and ophthalmologyWaste managementWater utilities and treatmentWealth managementWind